Many people dread tax time. But not you. For you, tax season doesn’t open a Lovecraftian portal that sucks money out of your accounts — instead, you find yourself with a refund. Regardless of how many ...

Stop reacting, start predicting: How AI spots whale moves that can make or break the market before anyone else notices. AI can process massive onchain data sets instantly, flagging transactions that ...

Timi is a news and deals writer who's been reporting on technology for over a decade. He loves breaking down complex subjects into easy-to-read pieces that keep you informed. But his recent passion ...

U.S. health officials are quickly taking regulatory action to build on findings from the administration’s research push into the “autism epidemic,” including a label update for a decades-old GSK drug ...

Imagine turning your old, “dumb” appliances into intelligent, Wi-Fi-enabled devices that respond to your voice, phone, or automation rules. Sounds futuristic, right? With the ESP8266 microcontroller, ...

Whether it's a job or being with friends, big words aren't always meant to be used in everyday conversation. Even if smart people can throw in complex words to show off their intellect, it's not ...

Have you ever wished you could quickly and quietly respond to a text while in a movie theatre without pulling out your phone. Or that you could see directions to the closest coffee shop without having ...

A new law in Hong Kong could pave the way for digital currencies tied to China. Credit...Simon Bailly Supported by By Meaghan Tobin Reporting from Hong Kong Digital currency has long posed a challenge ...

Threat actors have found a new way to deliver malicious software, commands, and links inside Ethereum smart contracts to evade security scans as attacks using code repositories evolve. Cybersecurity ...

Imagine walking into your home, and with a single voice command or tap on your phone, the lights dim, your favorite playlist starts, and the thermostat adjusts to the perfect temperature, all without ...

Glucagon-like peptide-1 (GLP-1) medications have grown in popularity over the last few years. Common examples include semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound).